Retrospective study results indicate lower adverse events, more rapid discharge, lower follow-up care costs, etc. with custom knee implants vs. standard, off the shelf devices.
Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis.